Table 1 |
|||||
|
Baseline characteristics of patients |
|||||
| Treatment group |
|||||
|
|
|||||
| Parameters |
CQ |
AQ |
SP |
AQ+SP |
AQ+AS |
|
|
|||||
| No. of patients |
42 |
39 |
40 |
83 |
83 |
| No. females (%) |
20 (47.6%) |
22 (56.4%) |
26 (65.0%) |
42 (50.6%) |
38 (46.3%) |
| Mean age (months. range) |
3.8 (0.6–14) |
3.3 (0.7–13) |
3.8 (0.5–12) |
3.9 (0.8–15) |
3.9 (0.5–15) |
| Mean weight (kg. range) |
12.9 (7–35) |
13.0 (7.8–40) |
12.1 (6–34) |
14.3 (7–50) |
14.6 (6–54.5) |
| Mean temperature (°C. range) |
38.4 (37.5–40.4) |
38.4 (37.5–40.8) |
38.5 (37.5–40.8) |
38.6 (37.5–41.0) |
38.6 (37.5–40.9) |
| Geometric mean parasite density (/μl. range) |
21156 (1020–199058) |
25559 (1142–199800) |
25640 (1010–199531) |
22368 (1050–199048) |
22905 (1005–184881) |
| Previous antimalrial therapy (%) |
2 (4.7%) |
1 (2.9%) |
2 (5.0%) |
2 (3.9%) |
3 (5.3%) |
| Mean haemoglobin (g/dl. range) |
10.1 (6.2–14.0) |
10.0 (6.4–14.2) |
9.7 (6.2–12.4) |
10.2 (6.2–15.6) |
10.4 (6.2–15.5) |
|
|
|||||
|
CQ. Chloroquine; AQ. Amodiaquine; SP. Sulphadoxine-pyrimethamine; AS. artesunate. |
|||||
|
Ménard et al. Malaria Journal 2007 6:65 doi:10.1186/1475-2875-6-65 |
|||||
